Osada T - Search Results

1

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.

Hanks BA, Holtzhausen A, Evans KS, Jamieson R, Gimpel P, Campbell OM, Hector-Greene M, Sun L, Tewari A, George A, Starr M, Nixon AB, Augustine C, Beasley G, Tyler DS, Osada T, Morse MA, Ling L, Lyerly HK, Blobe GC. Hanks BA, et al. Among authors: osada t. J Clin Invest. 2013 Sep;123(9):3925-40. doi: 10.1172/JCI65745. Epub 2013 Aug 8. J Clin Invest. 2013. PMID: 23925295 Free PMC article.

2

Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.

Osada T, Yang XY, Hartman ZC, Glass O, Hodges BL, Niedzwiecki D, Morse MA, Lyerly HK, Amalfitano A, Clay TM. Osada T, et al. Cancer Gene Ther. 2009 Sep;16(9):673-82. doi: 10.1038/cgt.2009.17. Epub 2009 Feb 20. Cancer Gene Ther. 2009. PMID: 19229288 Free PMC article.

3

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.

Osada T, Hsu D, Hammond S, Hobeika A, Devi G, Clay TM, Lyerly HK, Morse MA. Osada T, et al. Br J Cancer. 2010 Jan 5;102(1):124-33. doi: 10.1038/sj.bjc.6605364. Epub 2009 Dec 1. Br J Cancer. 2010. PMID: 19953093 Free PMC article.

4

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.

Hobeika A, Osada T, Serra D, Peplinski S, Hanson K, Tanaka Y, Niedzwiecki D, Chao N, Rizzieri D, Lyerly H, Clay T, Morse M. Hobeika A, et al. Among authors: osada t. Cytotherapy. 2008;10(3):289-302. doi: 10.1080/14653240801927040. Cytotherapy. 2008. PMID: 18418774

5

Protocol improvement and multisite validation of a digital soft agar colony formation assay for tumorigenic transformed cells intermingled in cell therapy products.

Bando K, Kusakawa S, Adachi H, Yamamoto M, Iwata M, Kitanaka A, Ogimura E, Osada T, Tamura M, Terai O, Watanabe T, Yoda T, Yotsumoto T, Zaizen K, Sato Y. Bando K, et al. Among authors: osada t. Cytotherapy. 2024 Mar 13:S1465-3249(24)00094-X. doi: 10.1016/j.jcyt.2024.03.005. Online ahead of print. Cytotherapy. 2024. PMID: 38556961 Free article.

6

Noninvasive intervention by transcranial ultrasound stimulation: Modulation of neural circuits and its clinical perspectives.

Osada T, Konishi S. Osada T, et al. Psychiatry Clin Neurosci. 2024 Mar 20. doi: 10.1111/pcn.13663. Online ahead of print. Psychiatry Clin Neurosci. 2024. PMID: 38505983

7

A Study of Factors Affecting Functional Outcomes in Patients With Successful Recanalization by Mechanical Thrombectomy.

Deguchi I, Osada T, Nakagami T, Kohyama S, Takahashi S. Deguchi I, et al. Among authors: osada t. Cureus. 2024 Feb 12;16(2):e54085. doi: 10.7759/cureus.54085. eCollection 2024 Feb. Cureus. 2024. PMID: 38487124 Free PMC article.

8

Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy.

Shibutani T, Goto R, Miyazaki I, Hashimoto A, Suzuki T, Ishida K, Haruma T, Osada T, Harada T, Fujita H, Ohkubo S. Shibutani T, et al. Among authors: osada t. Sci Rep. 2024 Feb 27;14(1):4784. doi: 10.1038/s41598-024-55488-6. Sci Rep. 2024. PMID: 38413675 Free PMC article. No abstract available.

9

Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury.

Jo-Watanabe A, Inaba T, Osada T, Hashimoto R, Nishizawa T, Okuno T, Ihara S, Touhara K, Hattori N, Oh-Hora M, Nureki O, Yokomizo T. Jo-Watanabe A, et al. Among authors: osada t. Nat Commun. 2024 Feb 27;15(1):1530. doi: 10.1038/s41467-024-45579-3. Nat Commun. 2024. PMID: 38413581 Free PMC article.

10

Diurnal Variation of Brain Activity in the Human Suprachiasmatic Nucleus.

Oka S, Ogawa A, Osada T, Tanaka M, Nakajima K, Kamagata K, Aoki S, Oshima Y, Tanaka S, Kirino E, Nakamura TJ, Konishi S. Oka S, et al. Among authors: osada t. J Neurosci. 2024 Feb 21;44(8):e1730232024. doi: 10.1523/JNEUROSCI.1730-23.2024. J Neurosci. 2024. PMID: 38238074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

739 results

Search Page